Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Philips Electronics Japan Opens Cardiac MRI Education Center
April 24, 2006
- NEW PRODUCTS
April 24, 2006
- Mochida Aims for Sales of \79 Bil. in New 3-Year Plan
April 17, 2006
- Nihon Medi-Physics Expands Consultation Services Regarding PET-CT
April 17, 2006
- Kissei Licenses Novel Diabetes Treatment to GSK
April 17, 2006
- Daiichi to Market Intrathecal Gagalon with Synchromed Infusion System
April 17, 2006
- Astellas Acquires Worldwide Rights to Amevive
April 17, 2006
- MEDICAL DEVICE NEWS IN BRIEF
April 17, 2006
- Kirin, Intercell to Develop Antibodies to Treat Pneumonia
April 17, 2006
- JMA's Relationship with LDP Needs Mending: Dr Karasawa
April 17, 2006
- Mr Iwasaki to Improve Labor-Management Relations via Dialogue: Pfizer Japan
April 17, 2006
- SEMINAR
April 17, 2006
- Kowa, Nikken's Integration Plan Accredited
April 17, 2006
- Sawai Expands Business with Wholesalers, Dispensing Pharmacies
April 17, 2006
- BUSINESS NEWS IN BRIEF
April 17, 2006
- GENERIC NEWS IN BRIEF
April 17, 2006
- Council to Collect Evidence on Pediatric Use of 5 Drugs
April 17, 2006
- Ordinance Issued on Designation of Vaccines as Orphan Drugs
April 17, 2006
- REGULATORY NEWS IN BRIEF
April 17, 2006
- BOOK
April 17, 2006
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…